Kaken Pharmaceutical Co., Ltd. (4521.T)

JPY 4192.0

(-2.58%)

EBITDA Summary of Kaken Pharmaceutical Co., Ltd.

  • Kaken Pharmaceutical Co., Ltd.'s latest annual EBITDA in 2023 was 12.26 Billion JPY , up 8.19% from previous year.
  • Kaken Pharmaceutical Co., Ltd.'s latest quarterly EBITDA in 2024 Q1 was 3.43 Billion JPY , up 179.65% from previous quarter.
  • Kaken Pharmaceutical Co., Ltd. reported an annual EBITDA of 10.56 Billion JPY in 2022, down -43.44% from previous year.
  • Kaken Pharmaceutical Co., Ltd. reported an annual EBITDA of 16.38 Billion JPY in 2021, down -2.49% from previous year.
  • Kaken Pharmaceutical Co., Ltd. reported a quarterly EBITDA of 3.49 Billion JPY for 2023 Q1, up 182.79% from previous quarter.
  • Kaken Pharmaceutical Co., Ltd. reported a quarterly EBITDA of N/A for 2023 FY, up 8.19% from previous quarter.

Annual EBITDA Chart of Kaken Pharmaceutical Co., Ltd. (2023 - 2004)

Historical Annual EBITDA of Kaken Pharmaceutical Co., Ltd. (2023 - 2004)

Year EBITDA EBITDA Growth
2023 12.26 Billion JPY 8.19%
2022 10.56 Billion JPY -43.44%
2021 16.38 Billion JPY -2.49%
2020 20.1 Billion JPY -29.78%
2019 29.37 Billion JPY 7.87%
2018 27.19 Billion JPY -9.52%
2017 29.9 Billion JPY -8.94%
2016 32.64 Billion JPY -12.48%
2015 37.39 Billion JPY 64.91%
2014 23.03 Billion JPY 26.07%
2013 18.07 Billion JPY 6.95%
2012 16.92 Billion JPY -20.17%
2011 17.14 Billion JPY 4.34%
2010 16.33 Billion JPY 15.57%
2009 13.97 Billion JPY 5.24%
2008 12.02 Billion JPY 5.65%
2007 11.35 Billion JPY 12.29%
2006 10.5 Billion JPY 1.92%
2005 10.49 Billion JPY 6.03%
2004 9.47 Billion JPY 0.0%

Peer EBITDA Comparison of Kaken Pharmaceutical Co., Ltd.

Name EBITDA EBITDA Difference
Pharma Foods International Co., Ltd. 6.02 Billion JPY -103.737%
Takeda Pharmaceutical Company Limited 874.6 Billion JPY 98.597%
Sumitomo Pharma Co., Ltd. -281.07 Billion JPY 104.364%
Shionogi & Co., Ltd. 186.7 Billion JPY 93.43%
Wakamoto Pharmaceutical Co.,Ltd. 570.97 Million JPY -2048.442%
Nippon Shinyaku Co., Ltd. 36.29 Billion JPY 66.197%
Eisai Co., Ltd. 103.1 Billion JPY 88.103%
Morishita Jintan Co., Ltd. 1.29 Billion JPY -848.724%
Hisamitsu Pharmaceutical Co., Inc. 18.34 Billion JPY 33.113%
Mochida Pharmaceutical Co., Ltd. 8.97 Billion JPY -36.71%
Fuso Pharmaceutical Industries,Ltd. 3.67 Billion JPY -234.251%
Nippon Chemiphar Co., Ltd. 1.4 Billion JPY -774.341%
Tsumura & Co. 30.77 Billion JPY 60.136%
Kissei Pharmaceutical Co., Ltd. 18.72 Billion JPY 34.471%
Torii Pharmaceutical Co., Ltd. 5.27 Billion JPY -132.726%
Towa Pharmaceutical Co., Ltd. 35.53 Billion JPY 65.48%
Fuji Pharma Co., Ltd. 6.88 Billion JPY -78.248%
Zeria Pharmaceutical Co., Ltd. 17.52 Billion JPY 29.989%
KYORIN Holdings, Inc. 10.29 Billion JPY -19.143%
Taiko Pharmaceutical Co.,Ltd. -3.75 Billion JPY 427.12%
Daito Pharmaceutical Co.,Ltd. 7.55 Billion JPY -62.412%
SymBio Pharmaceuticals Limited -714 Million JPY 1818.067%
MedRx Co., Ltd -884.51 Million JPY 1486.86%
Mizuho Medy Co.,Ltd. 5.53 Billion JPY -121.574%
Solasia Pharma K.K. -635 Million JPY 2031.811%
Modalis Therapeutics Corporation -2.37 Billion JPY 616.74%
ASKA Pharmaceutical Holdings Co.,Ltd. 9.16 Billion JPY -33.875%
Sawai Group Holdings Co., Ltd. 36.87 Billion JPY 66.732%
Cyfuse Biomedical K.K. -538.28 Million JPY 2378.887%
Toho Holdings Co., Ltd. 25.84 Billion JPY 52.536%
Koa Shoji Holdings Co.,Ltd. 5.1 Billion JPY -140.452%